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Prevalence of Coronary Artery Disease in Patients of Critical Limb Ischemia
Undergoing Endovascular Therapy in Asian Population
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Background: Peripheral vascular disease (PVD) is known to be a risk factor of sig-
niﬁcant coronary artery disease (CAD). The aim of this study was to analyze the
prevalence of CAD in patients of critical limb ischemia undergoing endovascular
therapy in Asian population.
Methods: A total of 286 consecutive critical limb ischemia (CLI) patients (pts) were
treated by endovascular therapy (EVT). 252 pts [male 76.1%, age 67.4  10.4] who
underwent coronary angioplasty (CAG) before or after EVT were enrolled between
November 2004 and October 2012. CAD was deﬁned as angiographic stenosis  50%
and signiﬁcant CAD as  70% stenosis.
Results: At baseline, the incidence of hypertension was 70.6%, diabetes 73.0%,
dyslipidemia 12.6%, cerebrovascular disease 17%, chronic kidney disease 23.0% and
atrial ﬁbrillation 9.1%. 58% pts had wounds (including DM foot, 49.2%), gangrene
9.1%, claudication 11.9%, resting pain 21.4% and Buerger’s disease 3.1%. CAG results
showed 62.5% with CAD and 50.6% with signiﬁcant CAD. Among pts with sig-
niﬁcant CAD, 16.2% had undergone previous percutaneous coronary intervention
(PCI) and 73 Pts (28.9%) received PCI during admission for EVT. Left main disease
was observed in 8.3%, multi-vessel disease in 35.7%, and chronic total occlusion
treated with medical therapy in 11.5%.
Conclusion: In this study, approximately 66.2% of pts with CLI undergoing EVT
may have signiﬁcant CAD in Asian population. Pts with PVD showed a signiﬁcant
association with CAD. Therefore, intensive anti- management and close clinical
follow up would be needed.A
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Background: There is limited data regarding differences in patency and clinical out-
comes of patients with life style limiting claudication and Critical Limb Ischemia (CLI).
Methods: Retrospective data analysis was conducted from the ongoing XLPAD
registry between July, 2005-October, 2013 to report clinical and revascularization
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Routcomes of Superﬁcial Femoral (SFA), Popliteal and Below the Knee (BTK) vessels
for Claudicants vs. CLI.
Results: A total of 559 interventions were performed on 343 patients (Claudicants
77% vs. CLI 23%). Diabetes Mellitus and Chronic Kidney disease were more prev-
alent in the CLI group as compared to Claudicants (71.8% vs. 54%, p<0.01 and
30.8% vs. 13.4%, p<0.01 respectively). Stent implantation was signiﬁcantly lower in
CLI patients (67.1% vs. 47.6%, p<0.01 respectively). Lesion lengths and frequency of
chronic total occlusions were similar in both groups (105.3  80.4 vs. 122.1  77.6,
p¼0.08; 65.0% vs. 75.1%, p¼0.2 respectively). Statin therapy was lesser used in CLI as
compared to Claudicants (76.1% vs. 87.3%, p¼0.05).Although repeat revasculariza-
tion rates were similar in both groups (16.2% vs. 17.6%, p¼0.7 respectively), surgical
revascularization and amputation rates were higher in CLI (14.5% vs. 4.9%, p<0.01
and 27.4% vs. 1.6%, p<0.01 respectively. Likewise, mortality rates were also higher in
the CLI cohort (9.4% vs. 3%, p¼0.008).
Conclusions: CLI patients have lower rates of stenting but signiﬁcantly higher fre-
quency of surgical revascularization and amputations.CRT-214
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Purpose: Patency evaluation of the self-expandable Pulsar-18 nitinol stent in patients
for the treatment of femoro-popliteal occlusive disease in a national multicenter
prospective all comers registry with a follow up period of 12 months.
Methods: Between 01/2012 and 08/2012 this all comers multicenter prospective
registry enrolled 118 patients (64 male patients) with 151 symptomatic femoro-
popliteal lesions Rutherford category II - V for recanalization and implantation of
the Pulsar-18 nitinol stent. Primary patency was deﬁned as no binary restenosis on
duplex ultrasound (PSVR < 2,5) and respectively no target lesion revascularization
performed within 12 months follow up. Drug eluting balloons were not allowed in
this registry.
Results: Average lesion length of the femoro-popliteal segment was 111,5 
71,4 mm. According to the TASC classiﬁcation 48 / 151 lesions were TASC D le-
sions. Mean stent implantation length was 122,7  64,5 mm. A total occlusion was
present in 84 of the 150 (56,7 %) treated lesions. Involvement of popliteal segment I-
III was present in 28 (18,7 %) lesions. Primary patency after 6 and 12 months was
91,7 % and 79,5%. The clinically driven overall freedom from target lesion revascu-
larization (FTLR) was 93,2 % after 6 months and 81 % after 12 months. ABI, pain
free walking distance and Rutherford category improved signiﬁcantly (p < 0,001) after
6 months and after 12 months. The restenosis rate in patients with diabetes (p ¼ 1,0)
and renal insufﬁciency (p ¼ 0,8) was not signiﬁcantly higher. Overlapping stents
showed a non-signiﬁcant trend for higher incidence of a signiﬁcant restenosis.
Popliteal stent implantation (P I - III segment) was not associated with a signiﬁcant
higher restenosis rate (p¼0,3) after 12 months. For recanalization of chronic totalocclusions (CTO) we did not ﬁnd a signiﬁcant difference (p ¼ 0,67) in restenosis rate
compared to non CTO lesions.
Conclusions: In this all comers registry using the Pulsar-18 self-expandable nitinol
stent endovascular intervention of femoro-popliteal disease with a mean lesion length
of 111,5 mm for revascularization had a promising primary patency and freedom from
target lesion revascularization rate after 6 and 12 months. Diabetes had no negative
impact on the patency rate. The primary patency rate in popliteal segments was
acceptable with 71,4 % after 12 months.
Renal Intervention
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Background: Coronary interventions are routinely performed using transradial
approach. But there is scarcity of studies evaluating the safety and efﬁcacy of transradial
approach to renal artery interventions. Thus further studies are needed to assess the
efﬁcacy and safety of this approach to renal artery interventions.
Methods: We conducted a retrospective chart review of all patients who underwent
renal artery intervention at our institution from January 2000 through May 2012 and
collected demographic, clinical and procedural characteristics. The patients were
divided into two groups based on transradial or transfemoral approach for the pro-
cedure and outcomes were evaluated during the index hospitalization. The primary
endpoint was the success rate of the approach, which was deﬁned as successful
completion of the procedure in achieving less than 30% residual stenosis without
crossing over to any alternative approach. Secondary endpoints were major access site
bleeding, time to discharge in hours after the end of the procedure, occurrence of
cerebrovascular accident (CVA) or transient ischemic attack (TIA), and all cause
mortality during the hospitalization.
Results: A total of 42 patients in the radial group and 35 patients in the femoral
group underwent renal artery interventions on 59 and 51 lesions respectively. There
were no signiﬁcant differences in the baseline demographic and clinical characteristics
between the two groups. There were a mean of 1.07 ( 0.51) stents placed in the radial
group and 1.23 ( 0.77) stents placed in the femoral group. The primary endpoint was
achieved in 40 (95%) and 35 (100%) patients in the radial and femoral groups
respectively (p¼0.50). There were no differences between radial and femoral groups in
regard to major access site bleeding (0% in each group), time to discharge in hours
(34.6  33.0 vs. 39.8  66.5, p¼ 0.25), CVA/TIA (2% vs. 0%, p¼1.00) and all cause
mortality during hospitalization (0% in each group) respectively.
Conclusion: Radial approach is an equally effective and safe alternative to transfemoral
approach for renal artery interventions.
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Background: In our center 11 patients (3 women. Average age 59.4  16 years)
affected by resistant hypertension were submitted to transcatheter renal denervation
(TREND) between November 2011 and June 2013. 6 patients presented signs of
hypertensive vascular damage. The patients were taking an average of 4 antihyper-
tensive drugs in dosage ceiling, including a diuretic. The values of mean arterial
pressure were: 176/98  17/14 mmHg.
